131 related articles for article (PubMed ID: 3254878)
1. Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies.
Ali SA; Eary JF; Warren SD; Badger CC; Krohn KA
Int J Rad Appl Instrum B; 1988; 15(5):557-61. PubMed ID: 3254878
[TBL] [Abstract][Full Text] [Related]
2. Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts.
Ali SA; Warren SD; Richter KY; Badger CC; Eary JF; Press OW; Krohn KA; Bernstein ID; Nelp WB
Cancer Res; 1990 Feb; 50(3 Suppl):783s-788s. PubMed ID: 2297724
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.
Reist CJ; Archer GE; Kurpad SN; Wikstrand CJ; Vaidyanathan G; Willingham MC; Moscatello DK; Wong AJ; Bigner DD; Zalutsky MR
Cancer Res; 1995 Oct; 55(19):4375-82. PubMed ID: 7671250
[TBL] [Abstract][Full Text] [Related]
4. Design of compounds having enhanced tumour uptake, using serum albumin as a carrier--Part II. In vivo studies.
Schilling U; Friedrich EA; Sinn H; Schrenk HH; Clorius JH; Maier-Borst W
Int J Rad Appl Instrum B; 1992 Aug; 19(6):685-95. PubMed ID: 1522023
[TBL] [Abstract][Full Text] [Related]
5. Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution.
Zalutsky MR; Xu FJ; Yu Y; Foulon CF; Zhao XG; Slade SK; Affleck DJ; Bast RC
Nucl Med Biol; 1999 Oct; 26(7):781-90. PubMed ID: 10628557
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution of p-iodobenzoyl (PIP) labeled antibodies in a murine lymphoma model.
Badger CC; Wilbur DS; Hadley SW; Fritzberg AR; Bernstein ID
Int J Rad Appl Instrum B; 1990; 17(4):381-7. PubMed ID: 2387747
[TBL] [Abstract][Full Text] [Related]
7. Comparative radiolabeling and distribution of a tumour-directed monoclonal antibody.
Turner CJ; Sykes TR; Longenecker BM; Noujaim AA
Int J Rad Appl Instrum B; 1988; 15(6):701-6. PubMed ID: 3251903
[TBL] [Abstract][Full Text] [Related]
8. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
Stein R; Goldenberg DM; Thorpe SR; Basu A; Mattes MJ
Cancer Res; 1995 Jul; 55(14):3132-9. PubMed ID: 7606734
[TBL] [Abstract][Full Text] [Related]
9. Preparation of biologically intact radioiodinated hyaluronan of high specific radioactivity: coupling of 125I-tyramine-cellobiose to amino groups after partial N-deacetylation.
Dahl LB; Laurent TC; Smedsrød B
Anal Biochem; 1988 Dec; 175(2):397-407. PubMed ID: 3071184
[TBL] [Abstract][Full Text] [Related]
10. Non-dehalogenation mechanisms for excretion of radioiodine after administration of labeled antibodies.
De Nardo GL; De Nardo SJ; Miyao NP; Mills SL; Peng JS; O'Grady LF; Epstein AL; Young WC
Int J Biol Markers; 1988; 3(1):1-9. PubMed ID: 3249042
[TBL] [Abstract][Full Text] [Related]
11. Residualizing and non-residualizing analogues of low-density lipoprotein as iodine-123 radiopharmaceuticals for imaging LDL catabolism.
Moerlein SM; Dalal KB; Ebbe SN; Yano Y; Budinger TF
Int J Rad Appl Instrum B; 1988; 15(2):141-9. PubMed ID: 3366617
[TBL] [Abstract][Full Text] [Related]
12. Radioiodination of a monoclonal antibody using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Garg S; Garg PK; Zhao XG; Friedman HS; Bigner DD; Zalutsky MR
Nucl Med Biol; 1993 Oct; 20(7):835-42. PubMed ID: 8241995
[TBL] [Abstract][Full Text] [Related]
13. Optimization of radioiodination and biotinylation of monoclonal antibody chimeric BR96: an indirect labeling using N-succinimidyl-3-(tri-n-butylstannyl)benzoate conjugate.
Chen J; Strand SE; Sjögren HO
Cancer Biother Radiopharm; 1996 Jun; 11(3):217-26. PubMed ID: 10851540
[TBL] [Abstract][Full Text] [Related]
14. Clearance from plasma of lymph chylomicrons and chylomicron remnants labelled with 125I-tyramine-cellobiose.
Ly HL; Mortimer BC; Baker E; Redgrave TG
Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):937-43. PubMed ID: 1417753
[TBL] [Abstract][Full Text] [Related]
15. Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma.
Carrasquillo JA; Mulshine JL; Bunn PA; Reynolds JC; Foon KA; Schroff RW; Perentesis P; Steis RG; Keenan AM; Horowitz M
J Nucl Med; 1987 Mar; 28(3):281-7. PubMed ID: 3102699
[TBL] [Abstract][Full Text] [Related]
16. Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Reist CJ; Archer GE; Wikstrand CJ; Bigner DD; Zalutsky MR
Cancer Res; 1997 Apr; 57(8):1510-5. PubMed ID: 9108453
[TBL] [Abstract][Full Text] [Related]
17. Isolation of mono- and di-iodine 125 tyramines for conjugation labelling.
Kakabakos SE; Livaniou E; Evangelatos SA; Evangelatos GP; Ithakissios DS
Eur J Nucl Med; 1991; 18(12):952-4. PubMed ID: 1778205
[TBL] [Abstract][Full Text] [Related]
18. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.
Wilbur DS; Hadley SW; Hylarides MD; Abrams PG; Beaumier PA; Morgan AC; Reno JM; Fritzberg AR
J Nucl Med; 1989 Feb; 30(2):216-26. PubMed ID: 2738650
[TBL] [Abstract][Full Text] [Related]
19. Site-specific conjugation of a radioiodinated phenethylamine derivative to a monoclonal antibody results in increased radioactivity localization in tumor.
Kurth M; Pèlegrin A; Rose K; Offord RE; Pochon S; Mach JP; Buchegger F
J Med Chem; 1993 Apr; 36(9):1255-61. PubMed ID: 8487262
[TBL] [Abstract][Full Text] [Related]
20. Improved iodine radiolabels for monoclonal antibody therapy.
Stein R; Govindan SV; Mattes MJ; Chen S; Reed L; Newsome G; McBride BJ; Griffiths GL; Hansen HJ; Goldenberg DM
Cancer Res; 2003 Jan; 63(1):111-8. PubMed ID: 12517786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
